Who says big pharma.(NEWS)(Brief article)Arnold, Matthew
As AstraZeneca looks to climb toward the top of biopharma companies by revenue by the end of the decade, smaller companies are looking to join the ranks of the unofficial Big Pharma club.
Apellis, Barinthus, Repare Among Latest to Trim Workforces January 14, 2025 · 103 min read · BioSpace Editorial Staff Gene therapy 5 Cardio Gene Therapies on the Near Horizon January 13, 2025 · 9 min read · Tristan Manalac FDA ...
Chris Ross, with the help of healthcare analysts GlobalData, takes a New Year look at the past, present and future of global pharma, and asks: what’s trending?
At issue is pbms’ opaque pricing, which takes a drug’s list price and shaves off discounts that the pbm wrangles from drugmakers. pbms claim they are a counterweight to big pharma. But critics argue that large pbms do not pass on the discounts to the health plans, instead keeping much...
(FDA). As research into the potential benefits of cannabinoids, and especially CBD, has gained momentum over the past several years, this deal could be an early indication of the acceptance of cannabis-based medicines in the world of big pharma. The question is, are there other companies out...
Big pharma is abandoning antibiotic research at a time when fears over superbugs are growing at an alarming rate. That's left just a few smaller firms to step into the breach between these drug-resistant bacteria and the public.
The group is looking to harness the outrage over the racist comments from comedian Tony Hinchcliffe. Jessica Piper 10/30/2024, 12:34pm ET A key Democratic group is spending big to text Puerto Rican voters about the racist remarks about the island delivered at a recent Donald Trump rally...
Another person, who said she pays $35 per month for insulin medication, was told that she would need to pay more for prescription drugs to line the pockets of Big Pharma. Finally, Anita, an OB-GYN who delivers babies, predicted: “It’s bad news, isn’t it?” before Thompson ...
Maxence Peignéis an investigative journalist withInvestigate Europe. Richard Bergström spent nearly three decades in the private pharmaceutical sector, including five years as head of its European lobby, the European Federation of Pharmaceutical Industries and Associations. 'That's a long time ago',...